decamethonium has been researched along with Acute Confusional Senile Dementia in 2 studies
decamethonium: RN given refers to parent cpd
decamethonium : A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muñoz-Ruiz, P | 1 |
| Rubio, L | 1 |
| García-Palomero, E | 1 |
| Dorronsoro, I | 1 |
| del Monte-Millán, M | 1 |
| Valenzuela, R | 1 |
| Usán, P | 1 |
| de Austria, C | 1 |
| Bartolini, M | 1 |
| Andrisano, V | 1 |
| Bidon-Chanal, A | 1 |
| Orozco, M | 1 |
| Luque, FJ | 1 |
| Medina, M | 1 |
| Martínez, A | 1 |
| Bembenek, SD | 1 |
| Keith, JM | 1 |
| Letavic, MA | 1 |
| Apodaca, R | 1 |
| Barbier, AJ | 1 |
| Dvorak, L | 1 |
| Aluisio, L | 1 |
| Miller, KL | 1 |
| Lovenberg, TW | 1 |
| Carruthers, NI | 1 |
2 other studies available for decamethonium and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Butyrylcholi | 2005 |
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Histamine H3 Antagonists | 2008 |